Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2016 Summary Global Markets Direct's, 'Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2016', provides an overview of the Organophosphate And Carbamate Poisoning pipeline landscape. The report provides comprehensive information on the therapeutics under development for Organophosphate And Carbamate Poisoning, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Organophosphate And Carbamate Poisoning and features dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Organophosphate And Carbamate Poisoning - The report reviews pipeline therapeutics for Organophosphate And Carbamate Poisoning by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Organophosphate And Carbamate Poisoning therapeutics and enlists all their major and minor projects - The report assesses Organophosphate And Carbamate Poisoning therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Organophosphate And Carbamate Poisoning Reasons To Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Organophosphate And Carbamate Poisoning - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Organophosphate And Carbamate Poisoning pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Content 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Organophosphate And Carbamate Poisoning Overview 6 Therapeutics Development 7 Pipeline Products for Organophosphate And Carbamate Poisoning - Overview 7 Pipeline Products for Organophosphate And Carbamate Poisoning - Comparative Analysis 8 Organophosphate And Carbamate Poisoning - Therapeutics under Development by Companies 9 Organophosphate And Carbamate Poisoning - Therapeutics under Investigation by Universities/Institutes 10 Organophosphate And Carbamate Poisoning - Pipeline Products Glance 11 Early Stage Products 11 Organophosphate And Carbamate Poisoning - Products under Development by Companies 12 Organophosphate And Carbamate Poisoning - Products under Investigation by Universities/Institutes 13 Organophosphate And Carbamate Poisoning - Companies Involved in Therapeutics Development 14 Countervail Corporation 14 Hager Biosciences, LLC 15 Organophosphate And Carbamate Poisoning - Therapeutics Assessment 16 Assessment by Monotherapy Products 16 Assessment by Target 17 Assessment by Mechanism of Action 19 Assessment by Route of Administration 21 Assessment by Molecule Type 23 Drug Profiles 25 AM-132 - Drug Profile 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 galantamine - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 PlantVax-1502-H-N - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 RS-194B - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecule for Organophosphate Poisoning - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Small Molecule to Inhibit PARP-1 and Activate AChE for Organophosphates Poisoning - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecules to Activate Acetylcholinesterase for Organophosphate Poisoning - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecules to Activate BuChE for Organophosphate and Carbamate Poisoning - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Organophosphate And Carbamate Poisoning - Discontinued Products 35 Organophosphate And Carbamate Poisoning - Product Development Milestones 36 Featured News & Press Releases 36 Feb 21, 2016: Israeli parent patent for the use of Galantamine and Antimuscarinic Agent For Organophosphorus Poisoning awarded 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables
Number of Products under Development for Organophosphate And Carbamate Poisoning, H1 2016 7 Number of Products under Development for Organophosphate And Carbamate Poisoning - Comparative Analysis, H1 2016 8 Number of Products under Development by Companies, H1 2016 9 Number of Products under Investigation by Universities/Institutes, H1 2016 10 Comparative Analysis by Early Stage Development, H1 2016 11 Products under Development by Companies, H1 2016 12 Products under Investigation by Universities/Institutes, H1 2016 13 Organophosphate And Carbamate Poisoning - Pipeline by Countervail Corporation, H1 2016 14 Organophosphate And Carbamate Poisoning - Pipeline by Hager Biosciences, LLC, H1 2016 15 Assessment by Monotherapy Products, H1 2016 16 Number of Products by Stage and Target, H1 2016 18 Number of Products by Stage and Mechanism of Action, H1 2016 20 Number of Products by Stage and Route of Administration, H1 2016 22 Number of Products by Stage and Molecule Type, H1 2016 24 Organophosphate And Carbamate Poisoning - Discontinued Products, H1 2016 35
Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing iRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliabRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.